NYSE:DBDDiebold Nixdorf Stock Price, Forecast & News

Diebold Nixdorf's stock was trading at $5.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DBD shares have increased by 22.1% and is now trading at $6.36. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Diebold Nixdorf in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Diebold Nixdorf.

Diebold Nixdorf is scheduled to release its next quarterly earnings announcement on Thursday, July 23rd 2020. View our earnings forecast for Diebold Nixdorf.

Diebold Nixdorf Inc (NYSE:DBD) issued its quarterly earnings results on Tuesday, May, 5th. The technology company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.06. The technology company had revenue of $910.70 million for the quarter, compared to analyst estimates of $915.67 million. Diebold Nixdorf had a negative return on equity of 1.98% and a negative net margin of 7.02%. The firm's revenue for the quarter was down 11.4% on a year-over-year basis. During the same quarter last year, the firm posted ($0.63) EPS. View Diebold Nixdorf's earnings history.

3 analysts have issued 12 month target prices for Diebold Nixdorf's stock. Their forecasts range from $7.00 to $19.00. On average, they anticipate Diebold Nixdorf's share price to reach $14.33 in the next year. This suggests a possible upside of 125.4% from the stock's current price. View analysts' price targets for Diebold Nixdorf.

News coverage about DBD stock has trended extremely positive on Friday, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Diebold Nixdorf earned a news impact score of 4.3 on InfoTrie's scale. They also assigned press coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutDiebold Nixdorf.

Some companies that are related to Diebold Nixdorf include Apple (AAPL), Dell (DELL), HP (HPQ), NCR (NCR), Super Micro Computer (SMCI), Stratasys (SSYS), 3D Systems (DDD), Avid Technology (AVID) and Kopin (KOPN). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Diebold Nixdorf investors own include AbbVie (ABBV), Chicago Bridge & Iron (CBI), Bristol-Myers Squibb (BMY), KKR & Co Inc (KKR), Philip Morris International (PM), Vector Group (VGR), Johnson Controls International (JCI), Mattel (MAT), Mondelez International (MDLZ) and Dunkin Brands Group (DNKN).

Diebold Nixdorf trades on the New York Stock Exchange (NYSE) under the ticker symbol "DBD."

Diebold Nixdorf's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.44%), Gamco Investors INC. ET AL (6.69%), Victory Capital Management Inc. (3.16%), Victory Capital Management Inc. (3.15%), State Street Corp (3.04%) and Smith Graham & Co. Investment Advisors LP (1.94%). Company insiders that own Diebold Nixdorf stock include Arthur F Anton, Bruce H Besanko, Ellen Costello, Gary G Greenfield, Gerrard Schmid, Jeffrey L Rutherford, Lauren States, Matthew Goldfarb, Olaf Robert Heyden, Phillip R Cox and Ulrich Naher. View institutional ownership trends for Diebold Nixdorf.

DBD stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, Russell Investments Group Ltd., BlackRock Inc., RBF Capital LLC, Morgan Stanley, Nuveen Asset Management LLC, Parametric Portfolio Associates LLC, and Canada Pension Plan Investment Board. View insider buying and selling activity for Diebold Nixdorf.

DBD stock was bought by a variety of institutional investors in the last quarter, including Luminus Management LLC, Smith Graham & Co. Investment Advisors LP, Invesco Ltd., Brigade Capital Management LP, AQR Capital Management LLC, JPMorgan Chase & Co., Quantitative Investment Management LLC, and Los Angeles Capital Management & Equity Research Inc.. Company insiders that have bought Diebold Nixdorf stock in the last two years include Arthur F Anton, Bruce H Besanko, Ellen Costello, Gary G Greenfield, Gerrard Schmid, Jeffrey L Rutherford, Lauren States, Matthew Goldfarb, Olaf Robert Heyden, and Ulrich Naher. View insider buying and selling activity for Diebold Nixdorf.

Shares of DBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DBD stock can currently be purchased for approximately $6.36.

Diebold Nixdorf has a market capitalization of $493.79 million and generates $4.41 billion in revenue each year. The technology company earns $-341,300,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Diebold Nixdorf employs 22,000 workers across the globe.

The official website for Diebold Nixdorf is www.dieboldnixdorf.com.

Diebold Nixdorf's mailing address is 5995 MAYFAIR RD P.O. BOX 3077, NORTH CANTON OH, 44720. The technology company can be reached via phone at 330-490-4000 or via email at [email protected]